FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310373606> ?p ?o ?g. }

• W4310373606 endingPage "739.e14" @default.
• W4310373606 startingPage "739.e1" @default.
• W4310373606 abstract "Background Cesarean delivery is the most performed major surgery among women, and surgical-site infections following a cesarean delivery are a significant source of postoperative morbidity. It is unclear if vaginal cleansing before a cesarean delivery decreases post-cesarean delivery infectious morbidity. Objective This study aimed to evaluate if preoperative vaginal cleansing with povidone-iodine among women undergoing a cesarean delivery after labor decreases postoperative infectious morbidity. Study Design This randomized clinical trial was conducted from August 3, 2015 to January 28, 2021, with 30 days of follow-up and the final follow-up completed on February 27, 2021. Patients met the inclusion criteria if they underwent a cesarean delivery after regular contractions with cervical dilation, rupture of membranes, or any cesarean delivery performed at >4 cm dilation. Participants were randomly assigned in a 1:1 ratio to either abdominal cleansing plus vaginal cleansing with 1% povidone-iodine or abdominal cleansing alone. The primary outcome was composite infectious morbidity including surgical-site infection, fever, endometritis, and wound complications within 30 days after the cesarean delivery. Secondary outcomes included individual components of the composite, length of hospital stay, postoperative hospitalization or outpatient treatment related to infectious morbidity, and empirical treatment for neonatal sepsis. Results A total of 608 subjects (304 vaginal cleansing group, 304 control group) were included in the intention-to-treat analysis. Patient characteristics were similar between groups. There was no significant difference in the primary composite outcome between the 2 groups (11.8% vs 11.5%; P=.90; relative risk, 1.0; 95% confidence interval, 0.7–1.6). Individual components of the composite and secondary outcomes were also not significantly different between the groups. Similar findings were observed in the as-treated analysis (11.3% vs 11.8%; P=.9; relative risk, 1.0; 95% confidence interval, 0.7–1.6). Conclusion Vaginal cleansing with povidone-iodine before an unscheduled cesarean delivery occurring after labor did not reduce the postoperative infectious morbidity. These findings do not support the routine use of vaginal cleansing for women undergoing a cesarean delivery after labor. Cesarean delivery is the most performed major surgery among women, and surgical-site infections following a cesarean delivery are a significant source of postoperative morbidity. It is unclear if vaginal cleansing before a cesarean delivery decreases post-cesarean delivery infectious morbidity. This study aimed to evaluate if preoperative vaginal cleansing with povidone-iodine among women undergoing a cesarean delivery after labor decreases postoperative infectious morbidity. This randomized clinical trial was conducted from August 3, 2015 to January 28, 2021, with 30 days of follow-up and the final follow-up completed on February 27, 2021. Patients met the inclusion criteria if they underwent a cesarean delivery after regular contractions with cervical dilation, rupture of membranes, or any cesarean delivery performed at >4 cm dilation. Participants were randomly assigned in a 1:1 ratio to either abdominal cleansing plus vaginal cleansing with 1% povidone-iodine or abdominal cleansing alone. The primary outcome was composite infectious morbidity including surgical-site infection, fever, endometritis, and wound complications within 30 days after the cesarean delivery. Secondary outcomes included individual components of the composite, length of hospital stay, postoperative hospitalization or outpatient treatment related to infectious morbidity, and empirical treatment for neonatal sepsis. A total of 608 subjects (304 vaginal cleansing group, 304 control group) were included in the intention-to-treat analysis. Patient characteristics were similar between groups. There was no significant difference in the primary composite outcome between the 2 groups (11.8% vs 11.5%; P=.90; relative risk, 1.0; 95% confidence interval, 0.7–1.6). Individual components of the composite and secondary outcomes were also not significantly different between the groups. Similar findings were observed in the as-treated analysis (11.3% vs 11.8%; P=.9; relative risk, 1.0; 95% confidence interval, 0.7–1.6). Vaginal cleansing with povidone-iodine before an unscheduled cesarean delivery occurring after labor did not reduce the postoperative infectious morbidity. These findings do not support the routine use of vaginal cleansing for women undergoing a cesarean delivery after labor." @default.
• W4310373606 created "2022-12-09" @default.
• W4310373606 creator A5033347731 @default.
• W4310373606 creator A5045876971 @default.
• W4310373606 creator A5059605490 @default.
• W4310373606 creator A5069313586 @default.
• W4310373606 creator A5084614665 @default.
• W4310373606 date "2023-06-01" @default.
• W4310373606 modified "2023-09-26" @default.
• W4310373606 title "Vaginal cleansing before unscheduled cesarean delivery to reduce infection: a randomized clinical trial" @default.
• W4310373606 cites W1771339314 @default.
• W4310373606 cites W1882804708 @default.
• W4310373606 cites W19718952 @default.
• W4310373606 cites W1984052453 @default.
• W4310373606 cites W1997225771 @default.
• W4310373606 cites W2000862853 @default.
• W4310373606 cites W2033722355 @default.
• W4310373606 cites W2049766055 @default.
• W4310373606 cites W2059707463 @default.
• W4310373606 cites W2062627493 @default.
• W4310373606 cites W2077174371 @default.
• W4310373606 cites W2080224405 @default.
• W4310373606 cites W2108696783 @default.
• W4310373606 cites W2126919203 @default.
• W4310373606 cites W2128542387 @default.
• W4310373606 cites W2139019618 @default.
• W4310373606 cites W2140195123 @default.
• W4310373606 cites W2158466965 @default.
• W4310373606 cites W2315032641 @default.
• W4310373606 cites W2328880452 @default.
• W4310373606 cites W2380482453 @default.
• W4310373606 cites W2402755812 @default.
• W4310373606 cites W2524784252 @default.
• W4310373606 cites W2590701739 @default.
• W4310373606 cites W2726261189 @default.
• W4310373606 cites W2744371561 @default.
• W4310373606 cites W2805561201 @default.
• W4310373606 cites W2806064548 @default.
• W4310373606 cites W2926356219 @default.
• W4310373606 cites W2932498578 @default.
• W4310373606 cites W3017105488 @default.
• W4310373606 cites W3108968864 @default.
• W4310373606 cites W3112882340 @default.
• W4310373606 cites W3114721008 @default.
• W4310373606 cites W3197141922 @default.
• W4310373606 cites W4236805817 @default.
• W4310373606 cites W4287348486 @default.
• W4310373606 cites W4300351379 @default.
• W4310373606 cites W4365787725 @default.
• W4310373606 doi "https://doi.org/10.1016/j.ajog.2022.11.1300" @default.
• W4310373606 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36462539" @default.
• W4310373606 hasPublicationYear "2023" @default.
• W4310373606 type Work @default.
• W4310373606 citedByCount "0" @default.
• W4310373606 crossrefType "journal-article" @default.
• W4310373606 hasAuthorship W4310373606A5033347731 @default.
• W4310373606 hasAuthorship W4310373606A5045876971 @default.
• W4310373606 hasAuthorship W4310373606A5059605490 @default.
• W4310373606 hasAuthorship W4310373606A5069313586 @default.
• W4310373606 hasAuthorship W4310373606A5084614665 @default.
• W4310373606 hasConcept C126322002 @default.
• W4310373606 hasConcept C131872663 @default.
• W4310373606 hasConcept C141071460 @default.
• W4310373606 hasConcept C168563851 @default.
• W4310373606 hasConcept C2775846227 @default.
• W4310373606 hasConcept C2776622691 @default.
• W4310373606 hasConcept C2778408130 @default.
• W4310373606 hasConcept C2779234561 @default.
• W4310373606 hasConcept C3020128735 @default.
• W4310373606 hasConcept C44249647 @default.
• W4310373606 hasConcept C46973012 @default.
• W4310373606 hasConcept C54355233 @default.
• W4310373606 hasConcept C71924100 @default.
• W4310373606 hasConcept C86803240 @default.
• W4310373606 hasConceptScore W4310373606C126322002 @default.
• W4310373606 hasConceptScore W4310373606C131872663 @default.
• W4310373606 hasConceptScore W4310373606C141071460 @default.
• W4310373606 hasConceptScore W4310373606C168563851 @default.
• W4310373606 hasConceptScore W4310373606C2775846227 @default.
• W4310373606 hasConceptScore W4310373606C2776622691 @default.
• W4310373606 hasConceptScore W4310373606C2778408130 @default.
• W4310373606 hasConceptScore W4310373606C2779234561 @default.
• W4310373606 hasConceptScore W4310373606C3020128735 @default.
• W4310373606 hasConceptScore W4310373606C44249647 @default.
• W4310373606 hasConceptScore W4310373606C46973012 @default.
• W4310373606 hasConceptScore W4310373606C54355233 @default.
• W4310373606 hasConceptScore W4310373606C71924100 @default.
• W4310373606 hasConceptScore W4310373606C86803240 @default.
• W4310373606 hasFunder F4320332161 @default.
• W4310373606 hasFunder F4320337472 @default.
• W4310373606 hasIssue "6" @default.
• W4310373606 hasLocation W43103736061 @default.
• W4310373606 hasLocation W43103736062 @default.
• W4310373606 hasOpenAccess W4310373606 @default.
• W4310373606 hasPrimaryLocation W43103736061 @default.
• W4310373606 hasRelatedWork W2031363923 @default.
• W4310373606 hasRelatedWork W2143472466 @default.
• W4310373606 hasRelatedWork W2416388972 @default.

• next